Integrating the Interleukins in the Biomarker Panel for the Diagnosis and Prognosis of Patients with Acute Coronary Syndromes: Unraveling a Multifaceted Conundrum.

While, in developed countries, there is a decreasing trend concerning the incidence and mortality associated with CAD, in low- or middle-income countries, the last few decades have brought a fulminant increase, not only in diagnosed cases, but also in mortality rates and CAD-related disability-adjusted life years (DALYs) [ 1 ].

also in 47,180 other papers